IREGA IVF Clinic of Cancun is dedicated to detail, combined with the latest technology to help you achieve your dream of parenthood. We commit to our patients to achieve their goal with the least costly means possible.
Pre-implantation Genetic Diagnosis (PGD) is one of our cutting-edge fertility treatments available to diagnosis abnormalities in embryos.
The Preimplantation Genetic Diagnosis (PGD) program at IREGA IVF Clinic of Cancun focuses on the stimulating and progressing promise of reducing the occurrence of genetic diseases. This program combines our expert technology and IVF experience under the meticulous guidance of Dr. Mayra and Dr. Adan.
Our testing for genetic disorders transpires prior to the transfer to the intended mother’s uterus. PGD at IREGA IVF Clinic of Cancun allows couples or individuals with serious inherited disorders to meaningfully lessen the risks of conceiving a child affected by the same disorder.
While we strongly are aware that PGD can’t put to rest all uncertainties of transmissible complications, our expert IVF specialists can give you a better outlook on a health pregnancy.
Our IREGA IVF Clinic of Cancun also implicates PGD services for gender selection.
Good Candidates for PGD
PGD is regularly accomplished for couples or individuals under the following circumstances:
Genetic disorders — for couples aware of genetic disorders through family history or based on carrier testing, PGD can be implemented to help evade a pregnancy or child born with a particular genetic condition.
Advanced maternal age — chromosomal abnormalities due to advancing maternal age are more likely to occur in women over the age of 35, leading to concerns such as Down Syndrome or early miscarriage. PGD can control the number and character of the chromosomes and regulate which embryos are the outcomes of a healthy, ongoing pregnancy.
Recurrent miscarriages — balanced reshuffle of chromosomes can lead to recurrent miscarriages. PGD can determine which eggs or embryos are the most likely to produce a healthy pregnancy, eliminating the chromosomes that have interlinked incorrectly.
Male factor infertility — in some cases of severe male factor infertility, a high rate of chromosomal abnormality has been seen in embryos that result from azoospermia. PGD testing can prevent implanting chromosomally abnormal embryos.
Patients of IREGA IVF Clinic of Cancun who are at risk for producing embryos with specific genetic abnormalities can find comfort under our personalized approach to testing.
The embryo biopsy is executed by our IVF embryologists. Once eggs are retrieved and fertilized with the with partner or donor sperm in the laboratory, embryos develop for 2 to 3 days into an 8 cell stage.
At the 8 cell stage, one cell from each embryo (embryo biopsy) is eradicated and located to the lab for chromosomal analysis. The embryo-specific results will then be communicated back to our embryologist prior to embryo transfer on Day 5.
Dr. Mayra and Dr. Adan will only transfer the blastocysts considered heritably healthy from the biopsy results.
Genetic Analysis with PGD
PGD at IREGA IVF Clinic of Cancun significantly holds the promise of reducing the incidence of genetic disease. Only those embryos that do not possess the disease-causing genes will be implanted.
Most chromosomally abnormal embryos do not implant or spontaneously abort shortly after implantation. The use of our exclusive PGD program allows provides a much better chance of achieving a full-term pregnancy with chromosomally healthy embryos.
Single Gene Disorders are those of known chromosomal origin where a single or multiple gene defect can lead to the presence of a certain disease. Single gene disorders include cystic fibrosis, sickle cell anemia, Tay Sachs disease, and Fragile X syndrome.
Translocation Disorders occur when pieces of chromosomal DNA break off and reattach to other chromosomes, which may lead to chromosomal rearrangements or result in repeated miscarriages.
Aneuploidy Disorders occur when additional or missing chromosomes during fertilization lead to significant genetic abnormalities such as Trisomy 21 (Down’s Syndrome), Trisomy 20, 22, 8, 13, 14, 15, 16, 17, and 18.